Category: Allergies & Sensitivities

The veterinary immunology and dermatology of canine allergies (atopic dermatitis, food hypersensitivity, flea allergy dermatitis) involve complex IgE-mediated immune responses and epidermal barrier dysfunction. In breeds like the Barbet, maintaining the integrity of the dense, curly coat and the underlying skin microbiome is critical for preventing secondary bacterial or Malassezia yeast infections.

The Veterinary Immunology & Epidermal Barrier Function hub analyzes the pathophysiology of canine sensitivities. Core attributes include the role of filaggrin protein defects in skin barrier permeability, the mechanism of pruritus (itching) mediated by cytokine IL-31, and the diagnostic protocol of elimination diet trials. The clinical value lies in moving from symptomatic relief to targeted immunomodulatory management.

Cytokine Signaling & Microbiome Dysbiosis

We examine modern pharmacological interventions like Oclacitinib (Apoquel), a Janus kinase (JAK) inhibitor that specifically blocks the neural itch pathway, and Lokivetmab (Cytopoint), a monoclonal antibody that targets IL-31. Our dermatological guides focus on managing the Barbet’s unique coat—preventing matting that traps moisture and creates a microenvironment for pathogen overgrowth. Understanding canine immunology enables effective, long-term dermatological care.

FAQ: Veterinary Immunology

What is atopic dermatitis in dogs? It is an inflammatory, chronically relapsing skin disease associated with allergies to environmental substances (pollens, house dust mites, mold). It is primarily driven by a genetic predisposition to produce IgE antibodies against these common antigens, leading to intense itching and secondary infections.
How do JAK inhibitors (like Apoquel) stop itching? When an allergen triggers the immune system, cells release cytokines (like IL-31). These cytokines bind to receptors on nerves, sending an ‘itch’ signal to the brain. This signaling pathway relies on Janus kinase (JAK) enzymes. Apoquel specifically blocks these enzymes, interrupting the signal and providing rapid relief from pruritus without the broad immunosuppression of corticosteroids.

Dermatology: Microbiome Health.